Showing results (151-160 of 199) with videos related to
Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Discovery of potential dual-target prodrugs of HIV-1 reverse transcriptase and nucleocapsid protein 7Songkai Sun, Boshi Huang, Zhuo Li, et al.Journal of Virology|October 12, 2023
4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1Pau Ribó-Molina, Hauke J Weiss, Balasubramanian Susma, et al.Biorxiv : the Preprint Server for Biology|October 17, 2024
Allosteric degraders induce CRL5 <sup>ASB8</sup> mediated degradation of XPO1Casey Elizabeth Hudman-Wing, Ho Yee Joyce Fung, Tolga Cagatay, et al.Antiviral Research|September 11, 2002
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infectionsRobert Snoeck, Graciela Andrei, Bahram Bodaghi, et al.Dalton Transactions (Cambridge, England : 2003)|August 16, 2012
CXCR4 chemokine receptor antagonists: nickel(II) complexes of configurationally restricted macrocyclesRachel Smith, Dana Huskens, Dirk Daelemans, et al.Science Translational Medicine|June 29, 2018
Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomasNatalia Saenz-Ponce, Rachael Pillay, Lilia Merida de Long, et al.Chemmedchem|August 4, 2020
Synthesis of Novel Nitroxoline Analogs with Potent Cathepsin B Exopeptidase Inhibitory ActivityTim Van de Walle, Marina Briand, Ana Mitrović, et al.Nature|January 13, 2017
PLA2G16 represents a switch between entry and clearance of PicornaviridaeJacqueline Staring, Eleonore von Castelmur, Vincent A Blomen, et al.European Journal of Medicinal Chemistry|May 4, 2015
Discovery of piperidin-4-yl-aminopyrimidine derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsZheng-Yong Wan, Jin Yao, Yuan Tao, et al.Cell Reports|December 5, 2025
Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potencyMarijke Verhaegen, Marianne Croonenborghs, Nidhi Sorout, et al.Pageof 20